The Clorox Company CLX
NYSE · Consumer Defensive · Household & Personal Products
$104.73
Close on Fri, 20 Nov 2026 · market value $12.7B
What the price is betting on
Priced for a lot to go rightAt $105, the price assumes revenue grows about 7.8% a year for five years, from $7.2B to about $10.3B by FY2031. That is about one and a half times what analysts expect for the next two years and well above the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 7.6% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than CLX? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$75
Base
$84
Bull
$94
Today $105
- Bear $75. Cash flow grows 2% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $84. Cash flow grows 4% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $94. Cash flow grows 6% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2027$7.6B$7.6B, on the path
- FY2028$8.2B$7.8B, below the path
- FY2029$8.8B$8B, below the path
- FY2030$9.5B$8.3B, below the path
- FY2031$10.3BThe full bet
Each year's revenue at 7.8% growth from $7.2B in the 12 months to September 2026.
At a glance
Consumer Defensive · Household & Personal Products · listed on NYSE
- Revenue, FY2026
- $6.7B
- Growth, 3 years a year
- −0.8%
- Cash margin
- 6%
- Net debt
- $5.4B
- Shares, 3-year change
- −1.7%
- Dividend yield
- 4.7%
What other consumer defensive prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.